Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-U3296
Fiducial Markers Market is predicted to value over CAGR of over 4.3% during the forecast period 2022 to 2028. Soaring funds, grants and investments by private and public organizations for research based on cancer, advancements in technology and rising acceptance of radiotherapy for oncological treatments are some of the key factors driving the growth of the market. The fiducial markers are used for accurately locating the tumor to provide the radiation dosage during the process of radiotherapy. Technological advancements in developing novel navigational systems for accurate product placement has boosted the fiducial markers market growth. For example, Veran Medical Technologies has developed an advanced navigational system, SPiN System, that helps in locating the target so that the fiducial market is placed appropriately for resection or radiation. This technology also offers a three-dimensional view of fiducials that shall help in generating the report for accurate treatment and diagnosis. Increasing awareness regarding radiotherapy methods like intensity modulated radiotherapy, stereotactic radiosurgery and image-guided radiotherapy is predicted to increase the acceptance of fiducial markers. The radiotherapy is highly preferred over chemotherapy considering the adverse side effects and complications related to targeted drug therapy and chemotherapy, thereby increasing the fiducial markers market demand throughout the forecast period. Radiotherapy is highly recommended for other cancer types as well. For example, in the stage 1 and stage 2 of the breast cancer, the patients are mainly prescribed with radiotherapy sessions and breast-conserving surgery. Conversely, the product implantation procedure is quite complex which might impede the adoption of these markers, thereby restraining the growth of the market. Furthermore, according to the NCBI, patients who underwent with the procedure of inserting transrectal fiducial markers for prostate cancer therapy of image guiding were diagnosed with haematospermia rectal bleeding, dysuria and haematuria which shall impede the proliferation of the market. Market Segmentation: By Product • Metal-based Markers o Pure Gold o Gold Alloys o Other Metal-based Markers • Polymer-based Markers • Other Fiducial Markers By Modality • CT/CBCT • MRI • Ultrasound • X-Ray By Application • Breast Cancer • Lung Cancer • Prostate Cancer • Head and Neck Cancer • Others By End User • Hospitals • Radiotherapy Center • Academic and Research Center By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is classified into product, modality, application, end user and region. The product segment is categorised into gold combination, polymer, liquid and other metals. The gold segment is predicted to hold the largest fiducial markers market share due to its superior stability and accurate visibility of these products with multiple modalities. Gold fiducial markers, along with the combination of other metals like platinum, nickel and titanium for enhancing their efficiency in visualising the tumors. For example, the gold fiducial markers, in combination with titanium stripes enhance the MRI image visibility. Multiple companies are heavily investing in research and development for designing products with improvements in efficiency. For example, IBA Dosimetry GmbH has announced a pure gold fiducial marker by the name Visicoil which is a helically shaped product that has a hollow core thereby reducing the prevalence of general complications like marker artifacts and migration. The modality segment is categorised into ultrasound, CT/CBCT, MRI and X-ray. The CT/CBCT segment is anticipated to lead the market owing to its ease of integration with current radiotherapy equipment and a low-level dosage exposure shall augment the growth of the segment. The ultrasound modality is predicted to grow at a substantial rate during the forecasted timeframe. This modality has a lower radiation toxicity as compared to other imaging modalities is a crucial factor for the proliferation of the market. The application segment is categorised into prostate, breast and lung cancer. The prostate cancer segment is predicted to lead the market owing to the rising acceptance of prostate cancer treatment across the world. Increased prevalence of lung cancer and advancements in technology for developing enhanced fiducial markers for an effective treatment of the disease. The end user segment is divided into radiotherapy centres, hospitals and academic research centres. The hospitals segment is anticipated to lead the market owing to the availability of novel radiotherapy equipment in healthcare institutes and rise in the number of multispecialty hospitals. Regional Analysis: The North America region is expected to dominate the market owing to improvements in the reimbursement policies, an impounding presence of key market players and rise in the number of awareness initiatives undertaken by government bodies. Furthermore, increased acceptance of novel imaging modalities and radiotherapy procedures shall propel the growth of the market. Competitive Landscape: Some of the crucial market players associated are CIVCO Radiotherapy, IZI Medical Products, Naslund Medical AB, Medtronic PLC, QlRad Inc., QFIX, Boston Scientific Corp., Nanovi A/S, Eckert & Ziegler, IBA Dosimetry GmbH. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global fiducial markers market by product, by modality, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Soaring funds, grants and investments by private and public organizations for research based on cancer, advancements in technology and rising acceptance of radiotherapy for oncological treatments are some of the key factors driving the growth of the market. The fiducial markers are used for accurately locating the tumor to provide the radiation dosage during the process of radiotherapy. Technological advancements in developing novel navigational systems for accurate product placement has boosted the fiducial markers market growth. For example, Veran Medical Technologies has developed an advanced navigational system, SPiN System, that helps in locating the target so that the fiducial market is placed appropriately for resection or radiation. This technology also offers a three-dimensional view of fiducials that shall help in generating the report for accurate treatment and diagnosis. Increasing awareness regarding radiotherapy methods like intensity modulated radiotherapy, stereotactic radiosurgery and image-guided radiotherapy is predicted to increase the acceptance of fiducial markers. The radiotherapy is highly preferred over chemotherapy considering the adverse side effects and complications related to targeted drug therapy and chemotherapy, thereby increasing the fiducial markers market demand throughout the forecast period. Radiotherapy is highly recommended for other cancer types as well. For example, in the stage 1 and stage 2 of the breast cancer, the patients are mainly prescribed with radiotherapy sessions and breast-conserving surgery. Conversely, the product implantation procedure is quite complex which might impede the adoption of these markers, thereby restraining the growth of the market. Furthermore, according to the NCBI, patients who underwent with the procedure of inserting transrectal fiducial markers for prostate cancer therapy of image guiding were diagnosed with haematospermia rectal bleeding, dysuria and haematuria which shall impede the proliferation of the market.
Market Segmentation:
By Product • Metal-based Markers o Pure Gold o Gold Alloys o Other Metal-based Markers • Polymer-based Markers • Other Fiducial Markers By Modality • CT/CBCT • MRI • Ultrasound • X-Ray By Application • Breast Cancer • Lung Cancer • Prostate Cancer • Head and Neck Cancer • Others By End User • Hospitals • Radiotherapy Center • Academic and Research Center By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is classified into product, modality, application, end user and region. The product segment is categorised into gold combination, polymer, liquid and other metals. The gold segment is predicted to hold the largest fiducial markers market share due to its superior stability and accurate visibility of these products with multiple modalities. Gold fiducial markers, along with the combination of other metals like platinum, nickel and titanium for enhancing their efficiency in visualising the tumors. For example, the gold fiducial markers, in combination with titanium stripes enhance the MRI image visibility. Multiple companies are heavily investing in research and development for designing products with improvements in efficiency. For example, IBA Dosimetry GmbH has announced a pure gold fiducial marker by the name Visicoil which is a helically shaped product that has a hollow core thereby reducing the prevalence of general complications like marker artifacts and migration. The modality segment is categorised into ultrasound, CT/CBCT, MRI and X-ray. The CT/CBCT segment is anticipated to lead the market owing to its ease of integration with current radiotherapy equipment and a low-level dosage exposure shall augment the growth of the segment. The ultrasound modality is predicted to grow at a substantial rate during the forecasted timeframe. This modality has a lower radiation toxicity as compared to other imaging modalities is a crucial factor for the proliferation of the market. The application segment is categorised into prostate, breast and lung cancer. The prostate cancer segment is predicted to lead the market owing to the rising acceptance of prostate cancer treatment across the world. Increased prevalence of lung cancer and advancements in technology for developing enhanced fiducial markers for an effective treatment of the disease. The end user segment is divided into radiotherapy centres, hospitals and academic research centres. The hospitals segment is anticipated to lead the market owing to the availability of novel radiotherapy equipment in healthcare institutes and rise in the number of multispecialty hospitals.
Regional Analysis:
The North America region is expected to dominate the market owing to improvements in the reimbursement policies, an impounding presence of key market players and rise in the number of awareness initiatives undertaken by government bodies. Furthermore, increased acceptance of novel imaging modalities and radiotherapy procedures shall propel the growth of the market.
Competitive Landscape:
Some of the crucial market players associated are CIVCO Radiotherapy, IZI Medical Products, Naslund Medical AB, Medtronic PLC, QlRad Inc., QFIX, Boston Scientific Corp., Nanovi A/S, Eckert & Ziegler, IBA Dosimetry GmbH.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global fiducial markers market by product, by modality, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2.Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Fiducial Markers Market, By Product Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1 Metal-based Markers 7.1.1.Pure Gold 7.1.2.Gold Alloys 7.1.3.Other Metal-based Markers 7.2 Polymer-based Markers 7.3 Other Fiducial Markers 8. Fiducial Markers Market, By Modality Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1 CT/CBCT 8.2 MRI 8.3 Ultrasound 8.4 X-Ray 9. Fiducial Markers Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1 Breast Cancer 9.2 Lung Cancer 9.3 Prostate Cancer 9.4 Head and Neck Cancer 9.5 Others 10. Fiducial Markers Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 10.1 Hospitals 10.2 Radiotherapy Center 10.3 Academic and Research Center 11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020 11.2.1. U.S. 11.2.2. Canada 11.2.3. Mexico 11.2.4. Rest of North America 11.3 Market Size (USD Mn) Forecast for North America 2022-2028 12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4 Market Size (US$ Mn) Forecast for Latin America 2022-2028 13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5 Switzerland 13.2.6. Spain 13.2.7. Russia 13.2.8. Poland 13.2.9. Rest of Western Europe 13.3 Market Size (US$ Mn) Forecast for Europe 2022-2028 14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2016-2020 14.2.1 Japan 14.2.2 China 14.2.3 Singapore 14.2.4 Korea 14.2.5 India 14.2.6 Australia and New Zealand 14.2.7 ASEAN 14.2.8 Rest of Asia Pacific 14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2016-2020 15.2.1 GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3 Market Size (US$ Mn) Forecast for MEA 2022-2028 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 16.1 CIVCO Radiotherapy 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 IZI Medical Products 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Naslund Medical AB 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 Medtronic PLC 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 QlRad Inc. 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 QFIX 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Boston Scientific Corp. 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Nanovi A/S 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Eckert & Ziegler 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 IBA Dosimetry GmbH 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. Competitive Intelligence and Competitive Matrix 18.1 Competitive Intelligence 18.2 Competitive Matrix 19. Major Deals and Strategic Alliances Analysis 19.1 Joint ventures 19.2 Mergers and acquisitions 19.3 Licensing and partnerships 19.4 Technology Collaborations 19.5 Strategic Divestments 19.6 Market Entry Strategies 20. Relevant Case Studies and Latest News Updates 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics